No Data
Express News | Pfizer’s Braftovi® Combination Regimen Demonstrates Improved Response in Patients With Braf V600E-Mutant Metastatic Colorectal Cancer
Pfizer's BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer
Four Years After Covid-19 Success, MRNA Vaccines Aren't Ready for Bird Flu -- Barrons.com
Options Market Statistics: Traders Buy Large Volumes of Meta Call Options as AI Investments Drive the Stock to Record Highs
News Highlights: Top Company News of the Day - Friday at 7 PM ET
Pfizer to Pay $60M in Kickback, False Claims Settlement